Mapping knowledge translation and innovation processes in Cancer Drug Development: The case of liposomal doxorubicin

15Citations
Citations of this article
51Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We explored how the knowledge translation and innovation processes are structured when theyresult in innovations, as in the case of liposomal doxorubicin research. In order to map the processes, a literature network analysis was made through Cytoscape and semantic analysis was performed by GOPubmed which is based in the controlled vocabularies MeSH (Medical Subject Headings) and GO (Gene Ontology). We found clusters related to different stages of the technological development (invention, innovation and imitation) and the knowledge translation process (preclinical, translational and clinical research), and we were able to map the historic emergence of Doxil as a paradigmatic nanodrug. This research could be a powerful methodological tool for decision-making and innovation management in drug delivery research.

Cite

CITATION STYLE

APA

Fajardo-Ortiz, D., Duran, L., Moreno, L., Ochoa, H., & Castaño, V. M. (2014). Mapping knowledge translation and innovation processes in Cancer Drug Development: The case of liposomal doxorubicin. Journal of Translational Medicine, 12(1). https://doi.org/10.1186/s12967-014-0227-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free